Published in Radiat Oncol on January 12, 2013
Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2010) 3.05
Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys (2007) 1.82
A retrospective study of surgery and reirradiation for recurrent ependymoma. Int J Radiat Oncol Biol Phys (2008) 1.34
Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer J (2005) 1.28
Tissue tolerance to reirradiation. Semin Radiat Oncol (2000) 1.17
Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.05
Dosimetric accuracy of planning and delivering small proton therapy fields. Phys Med Biol (2010) 0.92
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Int J Radiat Oncol Biol Phys (2008) 0.87
Proton therapy. Curr Probl Cancer (2010) 0.82
Salvage craniospinal irradiation with an intensity modulated radiotherapy technique for patients with disseminated neuraxis disease. Pract Radiat Oncol (2012) 0.81
Cerebral necrosis after 25Gy radiotherapy in childhood followed 28 years later by 54Gy radiotherapy. Clin Neurol Neurosurg (2007) 0.80
Supine proton beam craniospinal radiotherapy using a novel tabletop adapter. Med Dosim (2012) 0.80
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys (2002) 2.01
Pediatric CSI: are protons the only ethical approach? Int J Radiat Oncol Biol Phys (2013) 1.58
Proteolytic cleavage of cyclin E leads to inactivation of associated kinase activity and amplification of apoptosis in hematopoietic cells. Mol Cell Biol (2002) 1.05
Crystallographic and NMR analyses of UvsW and UvsW.1 from bacteriophage T4. J Biol Chem (2007) 0.89
Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above. Cancer (2002) 0.87
Overcoming the learning curve in supine pediatric proton craniospinal irradiation. J Am Coll Radiol (2012) 0.82
Definitive treatment of leptomeningeal spinal metastases in children. Pediatr Blood Cancer (2013) 0.78
Proton Radiotherapy for Midline Central Nervous System Lesions: A Class Solution. Oncology (2015) 0.77
Hypothalamic obesity syndrome: rare presentation of CNS+ B-cell lymphoblastic lymphoma. Pediatr Blood Cancer (2011) 0.75
Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome. Int J Radiat Oncol Biol Phys (2003) 0.75
Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams. Radiat Oncol (2014) 0.75
Radiation therapy at end of life in children. J Palliat Med (2014) 0.75
Dosimetric comparison between proton and photon beams in the moving gap region in cranio-spinal irradiation (CSI). Acta Oncol (2012) 0.75